Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Typhoid in 1993

J T La Brooy1

  • 1Department of Medicine, University of Queensland, North Queensland Clinical School, Townsville General Hospital.

The Medical Journal of Australia
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Typhoid fever, a significant global disease, has seen reduced mortality due to antibiotics like chloramphenicol. Emerging antibiotic resistance and new vaccine developments are key areas of current research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disseminated infection due to Nocardia transvalensis coincident with Cryptococcus neoformans variety gattii meningitis.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·1999
Same author

Dengue in Australia.

Journal of medical microbiology·1996
Same author

Chronic liver disease in asymptomatic hepatitis C antibody positive blood donors.

Australian and New Zealand journal of medicine·1993
Same author

HIV-related gastrointestinal disease.

The Medical journal of Australia·1993
Same author

Enteropathy in HIV infection.

Journal of acquired immune deficiency syndromes·1993
Same author

The antibody response to an oral Ty21a-based typhoid-cholera hybrid is unaffected by prior oral vaccination with Ty21a.

The Journal of infectious diseases·1992
Same journal

Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population.

The Medical journal of Australia·2026
Same journal

Striving for Racial Equity in Oral Cancer Research: A Case Study.

The Medical journal of Australia·2026
Same journal

Progressing Cross-Sector Collaboration for People With Eating Disorders and Higher Weight: Priority Actions From an Expert Roundtable Using a Modified Nominal Group Technique.

The Medical journal of Australia·2026
Same journal

Self-Poisoning With Prazosin and Its Off-Label Use in Australia, 2014-2024: Analysis of NSW Poisons Information Centre Data.

The Medical journal of Australia·2026
Same journal

Drivers of Vaccine Uptake for Aboriginal and Torres Strait Islander Children to Inform Tailored Strategies: A Qualitative Study Exploring Health Service Provider Perspective.

The Medical journal of Australia·2026
Same journal

Four Urgent Actions for the Rights to Culturally Safe Breastfeeding for Aboriginal and Torres Strait Islander Mothers and Babies to Breastfeed in Neonatal Intensive Care Environments.

The Medical journal of Australia·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Public Health
  • Microbiology

Background:

  • Typhoid fever remains a significant global health concern, particularly in developing regions.
  • Improvements in public health and effective antibiotic therapies have drastically reduced mortality rates.
  • Historically, chloramphenicol, introduced in the 1940s, lowered typhoid mortality from 25% to 1%.

Purpose of the Study:

  • To review recent advancements in typhoid fever management and prevention.
  • To highlight the challenges posed by emerging antibiotic resistance.
  • To discuss the development and potential impact of new typhoid vaccines.

Main Methods:

  • Literature review of recent studies on typhoid fever.
  • Analysis of trends in antibiotic resistance patterns.

Related Experiment Videos

  • Evaluation of new typhoid vaccine technologies.

    • Main Results:

    • Emergence of antibiotic resistance to previously effective treatments is a growing concern.
    • Aggressive interventions are improving outcomes for severe typhoid and complications like perforation.
    • Development of an oral typhoid vaccine offers a potentially more convenient alternative to parenteral vaccination.

    Conclusions:

    • Continued surveillance for antibiotic resistance is crucial for effective typhoid treatment.
    • Advancements in vaccines, including oral formulations, promise improved typhoid prevention strategies.
    • Integrated public health approaches remain essential for controlling typhoid globally.